Executive Director, Head of Clinical Development - Oncology

Lantheus (NASDAQ: LNTH) is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes.

Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland and United Kingdom, Lantheus has been providing radiopharmaceutical solutions for nearly 70 years.

Today, we’re expanding our portfolio and pipeline across oncology, neurology and cardiology. Through recent acquisitions, along with strategic partnerships across the life sciences ecosystem, we are accelerating our efforts to advance precision medicine and improve patient outcomes around the world.

At Lantheus we are purpose-driven, and every employee plays a vital role in our success. We’re dedicated to cultivating a high-growth, forward-thinking culture where innovation thrives and diverse perspectives drive meaningful progress.

Join us and be part of a company where your contributions make a real impact, because we know someone’s health is in our hands.

The Executive Director, Head of Clinical Development, Oncology is the senior leader responsible for shaping and executing the global clinical development strategy for oncology across the United States and EMEA. This position is based in Bedford, MA and requires a presence on-site of two - three days per week and is open to applicants authorized to work for any employer within the United States.

• Development and execution of the overall strategy for Lantheus’ pipeline in oncology indications.
• Build clinical development capabilities across the US and EMEA teams, ensuring consistent execution and alignment.
• Oversee company sponsored clinical research in oncology indications, including input on study-related documents.
• Supervision of medical and safety aspects of ongoing clinical trials
• Support launch strategies, life-cycle management, and expansion of indications for use (Phase 1-4 studies)
  Provide guidance and support for medical publications
• Liaise with regulatory authorities (early access, compassionate use or registry programs)
• Maintain awareness of internal and external developments (scientific, clinical, competitive, and regulatory) that could impact the development plan
• Attend relevant scientific meetings and conferences and support development of summaries of key data, presentations, or symposia
• Implementation of applicable guidelines of the quality assurance system of Lantheus
• Ensure compliance with applicable local and global laws, regulations, guidelines and company policies and procedures

• Doctorate degree in a relevant scientific field; board certification in Nuclear Medicine and/or Radiology. Experience in oncology is highly preferred.
• A minimum of 15 years of experience in drug development, with a proven track record in clinical trial planning and execution.
• Experience in Diagnostic Imaging development.
• Minimum of 8 years’ experience in leading an international Team; track record of success in building and leading teams. Strong managerial experience essential. Candidate must know the regulatory strategies of Diagnostic agent approval
• Deep understanding of regulatory requirements and industry guidelines (FDA, EMA, ICH) related to clinical development.
• Understanding of PET imaging and other imaging modalities is preferred
• Experience in drug development (clinical phases I-IV)
• Strong teamwork skills required to work with a cross functional team, but also ability to work independently
• Results oriented and driven by objectives: initiative, flexibility, good organizational, prioritization and time management skills
• Strong communication, presentation, and interpersonal skills to internal and external stakeholders
• Ab…